HAL (France)open access
Baroreflex activation therapy in heart failure - the Barostim-Enabled Neurohormonal Intervention for Improving Treatment of Heart Failure (BENEFIT-HF) trial rationale and design
Neurohormonal activation, Heart failure with reduced ejection fraction, Heart failure with mildly reduced ejection fraction, 0
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 226812
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.